THC Therapeutics Inc (THCT) Stock Price, Trades & News

THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.

Financial Strength

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	64
	9-Day RSI	37.74
	14-Day RSI	39.36
	6-1 Month Momentum %	350
	12-1 Month Momentum %	800

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

	Name	Current	Vs Industry		Vs History

GF Value Rank

	Name	Current	Vs Industry		Vs History

Financials (Next Earnings Date:2026-10-31 Est.)

Annual Quarterly TTM

THCT's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Gurus Latest Trades with OTCPK:THCT

No Available Data

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

THC Therapeutics Inc Executives

Details

GF Value™

THCT

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected issues with THCT. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil $)
	EPS (TTM) ($)	-0.066
	Beta	43.3596
	3-Year Sharpe Ratio	0.76
	3-Year Sortino Ratio	11.9
	Volatility %	641.75
	14-Day RSI	39.36
	14-Day ATR ($)	0.000091
	20-Day SMA ($)	0.000595
	12-1 Month Momentum %	800
	52-Week Range ($)	0.0001 - 0.1
	Shares Outstanding (Mil)	38.87

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	0
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

THC Therapeutics Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

THC Therapeutics Inc Stock Events

Financials Calendars

Event	Date	Price ($)
First quarter earnings results for 2027	2026-12-18	In 138 days
General meeting for 2025	2026-08-05	In 3 days
Second quarter earnings results for 2026	2026-07-31	0.00 (+0.00%)
Third quarter earnings results for 2026	2026-07-31	0.00 (+0.00%)
Annual report for 2024	2026-02-27	0.02 (+0.00%)
Third quarter earnings results for 2024	2024-11-13	0.00 (+0.00%)
Second quarter earnings results for 2024	2024-09-05	0.00 (+0.00%)
First quarter earnings results for 2024	2024-08-09	0.00 (+0.00%)
0.1:1 Stock Split	2018-12-10	0.88 (+44.54%)
0.071429:1 Stock Split	2016-06-10	10.22 (+10.61%)

Show

Entries

THC Therapeutics Inc Frequently Asked Questions

What is THC Therapeutics Inc(THCT)'s stock price today?

The current price of THCT is $0.00. The 52 week high of THCT is $0.10 and 52 week low is $0.00.

When is next earnings date of THC Therapeutics Inc(THCT)?

The next earnings date of THC Therapeutics Inc(THCT) is 2026-10-31 Est..

Does THC Therapeutics Inc(THCT) pay dividends? If so, how much?

THC Therapeutics Inc(THCT) does not pay dividend.

Guru Commentaries on OTCPK:THCT

No articles.

Press Release

	Subject	Date
	Kevin Bell CO-Founder & CEO of Kali Partners/VP of Tyson 2.0 joins THC Therapeutics	2021-12-29
	THC Therapeutics Has Entered Into Agreement for up to $50 Million in Funding With a Private Equity Firm for M&A in the Cannabis Industry	2021-09-10
	THC Therapeutics Appoints New CFO	2021-08-31
	THC Therapeutics Exploring Entry Into Silver Market as an Online Precious Metals Dealer	2021-05-26
	THC Therapeutics Hires Dr. Jesse Dean III, Former Chiropractor of the Memphis Grizzlies & Sports Agent	2021-04-27
	THC Therapeutics Has Completed the dHydronator(R) Consumer Model Design	2021-04-23
	Millennium BlockChain Announces $3 Million Investment in Robot Cache	2018-09-05
	Millennium BlockChain Announces Filing of Form 10 Registration Statement	2018-08-21
	Millennium BlockChain to Take 10% Position in Synergy Quantum, At a 50 Million Dollar Valuation	2018-06-25
	Millennium BlockChain Closes Previously Announced $3 Million Strategic Transaction with ImpactPPA	2018-06-14

10/Page

Articles on THC Therapeutics Inc

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.